Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Department of Urology, Foundation IRCCS Ca' Granda - Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Eur Urol Focus. 2022 Mar;8(2):555-562. doi: 10.1016/j.euf.2021.03.004. Epub 2021 Mar 20.
Discrepancies exist between patient-reported storage phase symptoms severity and International Prostate Symptom Score (IPSS) scores.
To investigate whether the Overactive Bladder questionnaire (OABq) can detect further storage phase lower urinary tract symptoms (LUTS) among patients complaining solely of voiding LUTS based on the IPSS questionnaire, and to address the real-life impact of voiding LUTS towards patients' quality of life (QoL).
DESIGN, SETTING, AND PARTICIPANTS: Data from 233 consecutive men seeking medical help for LUTS/benign prostate enlargement for the first time were analysed. All patients completed both the OABq and the IPSS questionnaire. In order to investigate patients with predominantly voiding phase symptoms, men with storage phase symptoms at IPSS were eventually excluded from the analysis. Patients with an OABq score of ≥40 were considered as those having moderate-to-severe storage LUTS.
Descriptive statistics and linear regression models tested the associations between OABq scores, IPSS, and IPSS-QoL.
OABq scores were higher in men with severe voiding symptoms than in men with mild voiding symptoms (p < 0.001). More than half of patients with predominant voiding symptoms, according to the IPSS questionnaire, depicted a pathologic OABq score. A higher rate of pathologic OABq scores was found in men with moderate/severe voiding symptoms than in those with mild scores (67.4% vs 49.6%, p < 0.001). At multivariable analysis, younger age (beta -0.1, p < 0.01), IPSS voiding subscore (beta 0.3, p < 0.001), and OABq score ≥40 (beta 1.1, p < 0.001) emerged as independent predictors of IPSS-QoL after accounting for prostate volume and flow max.
The OABq can detect the presence of further storage phase LUTS in patients presenting solely with voiding LUTS and IPSS suggestive of voiding phase symptoms. In addition, the OABq was associated with worse patient QoL regardless of the severity of voiding symptoms.
The Overactive Bladder questionnaire (OABq) is able to detect the presence of additional storage lower urinary tract symptoms (LUTS) in patients presenting solely with voiding LUTS according to the IPSS questionnaire. Moreover, the OABq is associated with worse quality of life in these patients regardless of the severity of voiding symptoms.
患者报告的储尿期症状严重程度与国际前列腺症状评分(IPSS)之间存在差异。
研究在仅根据 IPSS 问卷报告排尿期症状的患者中,膀胱过度活动症问卷(OABq)是否可以检测到更多的储尿期下尿路症状(LUTS),并探讨排尿期症状对患者生活质量(QoL)的实际影响。
设计、设置和参与者:对 233 名首次因 LUTS/良性前列腺增生寻求医疗帮助的连续男性患者的数据进行了分析。所有患者均完成了 OABq 和 IPSS 问卷。为了研究主要表现为排尿期症状的患者,最终排除了 IPSS 有储尿期症状的患者进行分析。OABq 评分≥40 的患者被认为有中重度储尿期 LUTS。
描述性统计和线性回归模型测试了 OABq 评分、IPSS 和 IPSS-QoL 之间的关联。
OABq 评分在排尿症状严重的男性中高于排尿症状轻度的男性(p<0.001)。根据 IPSS 问卷,超过一半的主要表现为排尿症状的患者有病理 OABq 评分。中重度排尿症状患者的病理 OABq 评分发生率高于轻度评分患者(67.4%比 49.6%,p<0.001)。在多变量分析中,年龄较轻(β-0.1,p<0.01)、IPSS 排尿子评分(β0.3,p<0.001)和 OABq 评分≥40(β1.1,p<0.001)是在考虑前列腺体积和最大流量后,独立预测 IPSS-QoL 的因素。
OABq 可检测出仅表现为排尿期症状和 IPSS 提示排尿期症状的患者存在进一步的储尿期 LUTS。此外,无论排尿症状的严重程度如何,OABq 与患者的 QoL 更差相关。
膀胱过度活动症问卷(OABq)能够在仅根据国际前列腺症状评分(IPSS)问卷报告排尿期症状的患者中检测到额外的储尿期下尿路症状(LUTS)的存在。此外,无论排尿症状的严重程度如何,OABq 与这些患者的生活质量更差相关。